MARKET

MNPR

MNPR

Monopar Therapeutics Inc
NASDAQ
40.84
-2.52
-5.81%
Opening 14:17 05/06 EDT
OPEN
40.25
PREV CLOSE
43.36
HIGH
43.59
LOW
40.25
VOLUME
11.68K
TURNOVER
--
52 WEEK HIGH
54.30
52 WEEK LOW
1.719
MARKET CAP
249.64M
P/E (TTM)
-9.9312
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MNPR last week (0428-0502)?
Weekly Report · 1d ago
Weekly Report: what happened at MNPR last week (0421-0425)?
Weekly Report · 04/28 11:43
Weekly Report: what happened at MNPR last week (0414-0418)?
Weekly Report · 04/21 11:43
Piper Sandler Remains a Buy on Monopar Therapeutics Inc (MNPR)
TipRanks · 04/21 10:57
Weekly Report: what happened at MNPR last week (0407-0411)?
Weekly Report · 04/14 11:31
Piper Sandler Remains a Buy on Monopar Therapeutics Inc (MNPR)
TipRanks · 04/14 10:27
Weekly Report: what happened at MNPR last week (0331-0404)?
Weekly Report · 04/07 11:30
Major Shareholder Sells Big Chunk of Monopar Therapeutics Stock!
TipRanks · 04/05 02:04
More
About MNPR
More
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.
Recently
Symbol
Price
%Change

Webull offers Monopar Therapeutics Inc stock information, including NASDAQ: MNPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNPR stock methods without spending real money on the virtual paper trading platform.